April 9, 2021
9 April 2021: Zina Kobbi CEO of AREMA will be the Keynote Speaker on the virtual conference “United Conference of Generic Medicine, Vaccines and Biosimilars” to […]
Arema
News
September 1, 2020
New guideline of bioequivalence was recently implemented in Morocco by the drug agency, Ministry of Health the link to the document: http://dmp.sante.gov.ma/upload/uploadinterne/Lignes%20directrices%20bioequivalence%20Maroc.pdf
March 26, 2020
Africa must “wake up” to the coronavirus threat and prepare for the worst, the head of the World Health Organization (WHO) DrTedros has said! Due to […]
June 1, 2019
News of Saudi Food and Drug Authority June 2019: the regulation of marketing exclusivity : this new procedure aims to promote the availability of the important […]
May 30, 2019
The partnership between Europe and developing countries for clinical trials (EDCTP) is providing funding of 10 million euros over five years for the “WANECAM 2” project. […]
May 3, 2019
The 20th Ordinary Meeting of the ECOWAS Health Ministers’ Assembly (HMA) will take place from April 29 to May 3, 2019, in Cotonou, Republic of Benin. […]
March 26, 2019
News regulation and requirements for medical devices dossier preparation for registration in Burkina Fasso .
January 2, 2019
New : AREMA as a company specialized in Regulatory Affairs, registration & business development opportunities in Africa (17 countries), enlarge alliances and services and offer now […]
January 1, 2019
October 9, 2018
AREMA will be visiting CPHI WORLDWIDE (from 9 to 11 October). If you wish to meet AREMA representative and know more about our services , please […]
July 29, 2018
05 July 2018: WHO launched a pilot project for prequalifying biotherapeutic medicines, a step towards making some of the most expensive treatments for cancer more widely […]
June 6, 2018
SFDA (Saudi Food & Drug Authority) adopted on 06 June 2018 , Good Manufacturing Practice for Blood Establishments. The purpose of this document is to provide […]
June 4, 2018
04 June 2018: FDA approves first biosimilar to Neulasta (pegfilgrastim) of Mylan GmbH. This porduct helps to reduce the risk of infection during cancer treatment . […]
April 24, 2018
